European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Global 2026: Pre-Conference Coverage
Powered by ![]()
All the vital news, analysis, and commentary curated by our industry experts.
ESCMID Global is the annual congress of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) (formerly ECCMID).
The European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Global Annual Meeting 2026 will take place in Munich, Germany, between April 17 and 21.
In advance of the confernece, GlobalData highlighted highly anticipated and noteworthy abstracts in this Pre-Conference Coverage report.
Scope
Indications, companies, and therapies discussed:
RSV
•Enanta Pharmaceuticals – Zelicapavir
Chikungunya virus
•Evotec – EVT894
Influenza
•Moderna – mRNA-1010
COVID-19
•Shionogi – Secutrelvir
HSV
•AICuris – Pritelivir
•Innovative Moleules – Adibelivir
Hepatitis B
•Helmholtz-Zentrum fur Umweltforschung – TherVacB
Complicated urinary tract infections/axute pyelonephritis
•Wockhardt – Zaynich
Invasive fungal infections
•F2G – Olorofim
•Scynexis – SCY-247
Reasons to Buy
This powerpoint-based deliverable highlights noteworthy conference abstracts, and the potential implications for your strategy, covering disease areas such as RSV, influenza, COVID-19, HSV, UTIs, fungal infections, and more.
Evotec
Moderna
Shionogi
AICuris
Innovative Molecules
Helmholtz-Zentrum fur Umweltforschung
Wockhardt
F2G
Scynexis
Table of Contents
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Related reports
View more Pharmaceuticals reports